| # | Title | Journal | Year | Citations |
|---|
| 1 | Secondary Prevention of Venous Thromboembolic Events in Patients With Active Cancer: Enoxaparin Alone Versus Initial Enoxaparin Followed by Warfarin for a 180-Day Period | Clinical and Applied Thrombosis/Hemostasis | 2006 | 348 |
| 2 | COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation | Clinical and Applied Thrombosis/Hemostasis | 2020 | 304 |
| 3 | Pharmacology, Pharmacokinetics, and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor | Clinical and Applied Thrombosis/Hemostasis | 2009 | 289 |
| 4 | The Relation Between Atherosclerosis and the Neutrophil–Lymphocyte Ratio | Clinical and Applied Thrombosis/Hemostasis | 2016 | 271 |
| 5 | Platelets as Predictors of Vascular Risk: Is There a Practical Index of Platelet Activity? | Clinical and Applied Thrombosis/Hemostasis | 2003 | 253 |
| 6 | A Practical Concept for Preoperative Identification of Patients with Impaired Primary Hemostasis | Clinical and Applied Thrombosis/Hemostasis | 2004 | 192 |
| 7 | Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium | Clinical and Applied Thrombosis/Hemostasis | 2019 | 174 |
| 8 | Association of Monocyte-to-HDL Cholesterol Ratio with Slow Coronary Flow is Linked to Systemic Inflammation | Clinical and Applied Thrombosis/Hemostasis | 2016 | 152 |
| 9 | Low-Molecular-Weight Heparin Versus Placebo for the Prevention of Venous Thromboembolism in Metastatic Breast Cancer or Stage III/IV Lung Cancer | Clinical and Applied Thrombosis/Hemostasis | 2012 | 147 |
| 10 | Correlation of Neutrophil to Lymphocyte Ratio With the Presence and Severity of Metabolic Syndrome | Clinical and Applied Thrombosis/Hemostasis | 2014 | 147 |
| 11 | Characterization of an In Vitro Platelet Function Analyzer, PFA-100™ | Clinical and Applied Thrombosis/Hemostasis | 1996 | 146 |
| 12 | Mean Platelet Volume as a Diagnostic Marker for Cardiovascular Disease | Clinical and Applied Thrombosis/Hemostasis | 2012 | 140 |
| 13 | State-of-the-Art Review: Hemostats, Sealants, and Adhesives II: Update As Well As How and When to Use the Components of the Surgical Toolbox | Clinical and Applied Thrombosis/Hemostasis | 2010 | 138 |
| 14 | Completion of the Updated Caprini Risk Assessment Model (2013 Version) | Clinical and Applied Thrombosis/Hemostasis | 2019 | 137 |
| 15 | Association Between Neutrophil to Lymphocyte Ratio and Severity of Coronary Artery Disease | Clinical and Applied Thrombosis/Hemostasis | 2014 | 129 |
| 16 | Diagnosis and Management of Isolated Subsegmental Pulmonary Embolism: Review and Assessment of the Options | Clinical and Applied Thrombosis/Hemostasis | 2012 | 126 |
| 17 | Dengue After COVID-19 Vaccination: Possible and Might be Missed | Clinical and Applied Thrombosis/Hemostasis | 2021 | 120 |
| 18 | Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies | Clinical and Applied Thrombosis/Hemostasis | 2018 | 114 |
| 19 | Thrombosis and a Hypercoagulable State in HIV-Infected Patients | Clinical and Applied Thrombosis/Hemostasis | 2004 | 104 |
| 20 | A Practical Concept for Preoperative Management of Patients With Impaired Primary Hemostasis | Clinical and Applied Thrombosis/Hemostasis | 2004 | 100 |
| 21 | COVID-19 and Hypercoagulability: A Review | Clinical and Applied Thrombosis/Hemostasis | 2020 | 99 |
| 22 | Approach to the Assessment of Platelet Function: Comparison between Optical-based Platelet-rich Plasma and Impedance-based Whole Blood Platelet Aggregation Methods | Clinical and Applied Thrombosis/Hemostasis | 2005 | 95 |
| 23 | Biomarkers of Inflammation, Growth Factor, and Coagulation Activation in Patients With Sickle Cell Disease | Clinical and Applied Thrombosis/Hemostasis | 2012 | 94 |
| 24 | Oral Contraceptives and HRT Risk of Thrombosis | Clinical and Applied Thrombosis/Hemostasis | 2018 | 92 |
| 25 | Acute Respiratory Distress Syndrome as an Organ Phenotype of Vascular Microthrombotic Disease: Based on Hemostatic Theory and Endothelial Molecular Pathogenesis | Clinical and Applied Thrombosis/Hemostasis | 2019 | 92 |
| 26 | Iron Deficiency and Thrombosis: Literature Review | Clinical and Applied Thrombosis/Hemostasis | 2004 | 91 |
| 27 | Plateletcrit, Mean Platelet Volume, Platelet Distribution Width: Its Expected Values and Correlation With Parallel Red Blood Cell Parameters | Clinical and Applied Thrombosis/Hemostasis | 2004 | 91 |
| 28 | The Influence of Low Platelet Count on Whole Blood Aggregometry Assessed by Multiplate | Clinical and Applied Thrombosis/Hemostasis | 2011 | 91 |
| 29 | Long-Term Outcomes in Acute Pulmonary Thromboembolism | Clinical and Applied Thrombosis/Hemostasis | 2012 | 87 |
| 30 | White Blood Cell Counts, Leukocyte Ratios, and Eosinophils as Inflammatory Markers in Patients With Coronary Artery Disease | Clinical and Applied Thrombosis/Hemostasis | 2015 | 87 |
| 31 | Diagnostic Value of D-Dimer in COVID-19: A Meta-Analysis and Meta-Regression | Clinical and Applied Thrombosis/Hemostasis | 2021 | 87 |
| 32 | Disseminated Intravascular Coagulation: A Review of Etiology, Pathophysiology, Diagnosis, and Management: Guidelines for Care | Clinical and Applied Thrombosis/Hemostasis | 2002 | 85 |
| 33 | Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome | Clinical and Applied Thrombosis/Hemostasis | 2016 | 85 |
| 34 | COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response | Clinical and Applied Thrombosis/Hemostasis | 2020 | 82 |
| 35 | Effects of Losartan and Simvastatin on Monocyte-Derived Microparticles in Hypertensive Patients With and Without Type 2 Diabetes Mellitus | Clinical and Applied Thrombosis/Hemostasis | 2004 | 80 |
| 36 | Evaluation of Soluble P-Selectin as a Marker for the Diagnosis of Deep Venous Thrombosis | Clinical and Applied Thrombosis/Hemostasis | 2011 | 80 |
| 37 | Evaluation of the Prothrombin Time for Measuring Rivaroxaban Plasma Concentrations Using Calibrators and Controls | Clinical and Applied Thrombosis/Hemostasis | 2012 | 79 |
| 38 | Evaluation of New Japanese Diagnostic Criteria for Disseminated Intravascular Coagulation in Critically Ill Patients | Clinical and Applied Thrombosis/Hemostasis | 2005 | 77 |
| 39 | Postprandial Lipemia is Associated With Platelet and Monocyte Activation and Increased Monocyte Cytokine Expression in Normolipemic Men | Clinical and Applied Thrombosis/Hemostasis | 2002 | 76 |
| 40 | Neutrophils/Lymphocytes Ratio in Patients With Cardiac Syndrome X and Its Association With Carotid Intima–Media Thickness | Clinical and Applied Thrombosis/Hemostasis | 2014 | 75 |
| 41 | Eosinophilia and Thrombophilia in Churg Strauss Syndrome: A Clinical and Pathogenetic Overview | Clinical and Applied Thrombosis/Hemostasis | 2010 | 73 |
| 42 | Prevention and Treatment of Venous Thromboembolism | Clinical and Applied Thrombosis/Hemostasis | 2013 | 73 |
| 43 | State-of-the-Art Review : The Effect of Antiplatelet Drugs, Heparin, and Preanalytical Variables on Platelet Function Detected by the Platelet Function Analyzer (PFA-100®) | Clinical and Applied Thrombosis/Hemostasis | 1999 | 72 |
| 44 | Venous Thrombosis Among Patients with AIDS | Clinical and Applied Thrombosis/Hemostasis | 2004 | 72 |
| 45 | The Role of Plasma Exchange in HELLP Syndrome | Clinical and Applied Thrombosis/Hemostasis | 2005 | 71 |
| 46 | Expected Viscosity After COVID-19 Vaccination, Hyperviscosity and Previous COVID-19 | Clinical and Applied Thrombosis/Hemostasis | 2021 | 71 |
| 47 | Acquired Protein C and Protein S Deficiency in HIV-Infected Patients | Clinical and Applied Thrombosis/Hemostasis | 2003 | 70 |
| 48 | Recurrent Miscarriage Syndrome and Infertility Due to Blood Coagulation Protein/Platelet Defects: A Review and Update | Clinical and Applied Thrombosis/Hemostasis | 2005 | 70 |
| 49 | Mean Platelet Volume: A New Predictor in Confirming Acute Appendicitis Diagnosis | Clinical and Applied Thrombosis/Hemostasis | 2011 | 70 |
| 50 | Synthetic Pentasaccharides Do Not Cause Platelet Activation by Antiheparin-Platelet Factor 4 Antibodies | Clinical and Applied Thrombosis/Hemostasis | 1999 | 69 |
